5 results
management activetb latenttb tb apml cancer criticalcare differentiation dyspnea hematology malignancy shock syndrome
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Diagnosis: Latent ... Tuberculin skin test ... Treatment: Active ... #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Diagnosis: Latent ... Tuberculin skin test ... Treatment: Active ... #TB #Diagnosis ... #Management #Treatment
Dyspnea - Considerations with Malignancy Directly Malignancy Related: - Lymphangitic spread to lung - Malignant pleural effusion
metastases Treatment ... Changes in Pre-Test ... NEJMcps1414168 #dyspnea #algorithm ... #differential # ... diagnosis #oncology
Shock - Differential Diagnosis Framework - MAP <65. SBP <90, drop in SBP > 40 -
Shock - Differential ... Diagnosis Framework ... SBP > 40 - End-organ ... • Obstructive: Pulmonary ... #algorithm #treatment
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... initiation • Differential ... Renal Failure Treatment ... management #hematology #oncology
No results found for "Origin treatment idsa test differential tuberculosis diagnosis algorithm pulmonary oncology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Origin #treatment #idsa #test #differential #tuberculosis #diagnosis #algorithm #pulmonary #oncology